Literature DB >> 11279904

Headache associated with pituitary adenomas.

T Abe1, K Matsumoto, J Kuwazawa, I Toyoda, K Sasaki.   

Abstract

The objectives of this study were to analyze the characteristics of headache in patients with pituitary adenoma and to investigate the mechanisms involved. Fifty-one patients (27 females and 24 males) with pituitary adenoma were examined. Nineteen (37.3%) of these patients (13 females and 6 males) had headache preoperatively. Most commonly, the headache was generalized (42.1%); overall headache was more frequent in the anterior half of the head (84.2%). Seventeen (89.5%) patients had bilateral headache. Headache was usually described as head heaviness (57.9%) and continuous (57.9%). Pulsating headache and dull pain were only reported by the female patients and were mostly intermittent. The mean age of patients with headache was younger than that of those without headache. Headache was more prevalent in patients with a prolactin-secreting adenoma (57.1%). There were no correlations between visual disturbances, hypopituitarism, tumor size, or cavernous sinus invasion and headache. Hemorrhagic pituitary adenoma in 4 (57.1%) of 7 patients did not always contribute to headache. The headache was improved after surgery in 14 (73.6%) of the 19 patients. In the male patients who survived postoperatively (5 of 6), headache was improved.

Entities:  

Mesh:

Year:  1998        PMID: 11279904     DOI: 10.1046/j.1526-4610.1998.3810782.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  24 in total

Review 1.  Headache in patients with cancer.

Authors:  Samuel A Goldlust; Jerome J Graber; Dana F Bossert; Edward K Avila
Journal:  Curr Pain Headache Rep       Date:  2010-12

2.  Significant improvement of intractable headache after transsphenoidal surgery in patients with pituitary adenomas; preoperative neuroradiological evaluation and intraoperative intrasellar pressure measurement.

Authors:  Yasuhiko Hayashi; Daisuke Kita; Masayuki Iwato; Issei Fukui; Masahiro Oishi; Taishi Tsutsui; Osamu Tachibana; Mitsutoshi Nakada
Journal:  Pituitary       Date:  2016-04       Impact factor: 4.107

Review 3.  It IS a tumor -- current review of headache and brain tumor.

Authors:  Kevin Kahn; Alan Finkel
Journal:  Curr Pain Headache Rep       Date:  2014-06

4.  Headache related to brain tumors.

Authors:  Monica Loghin; Victor A Levin
Journal:  Curr Treat Options Neurol       Date:  2006-01       Impact factor: 3.598

5.  The association of pituitary tumors and headache.

Authors:  Miles J Levy
Journal:  Curr Neurol Neurosci Rep       Date:  2011-04       Impact factor: 5.081

6.  The association between calcitonin gene-related peptide (CGRP), substance P and headache in pituitary tumours.

Authors:  M J Levy; J D Classey; S Maneesri; K Meeran; M Powell; P J Goadsby
Journal:  Pituitary       Date:  2004       Impact factor: 4.107

7.  Presence of headache and headache types in patients with tumors of the sellar region-can surgery solve the problem? Results of a prospective single center study.

Authors:  Sonja Siegel; Renata Weber Carneiro; Michael Buchfelder; Bernadette Kleist; Agnieszka Grzywotz; Rolf Buslei; Ulrike Bingel; Georg Brabant; Thomas Schenk; Ilonka Kreitschmann-Andermahr
Journal:  Endocrine       Date:  2017-02-27       Impact factor: 3.633

Review 8.  Clinical Presentation and Management of Headache in Pituitary Tumors.

Authors:  Himanshu Suri; Carrie Dougherty
Journal:  Curr Pain Headache Rep       Date:  2018-06-15

9.  Assessment of hemorrhage in pituitary macroadenoma by T2*-weighted gradient-echo MR imaging.

Authors:  M Tosaka; N Sato; J Hirato; H Fujimaki; R Yamaguchi; H Kohga; K Hashimoto; M Yamada; M Mori; N Saito; Y Yoshimoto
Journal:  AJNR Am J Neuroradiol       Date:  2007-09-26       Impact factor: 3.825

10.  [Migraine recurrence due to intracranial metastasis of a thyroid carcinoma].

Authors:  C J Schankin; J Wagner; M Elstner; V M Reinisch; A Straube
Journal:  Nervenarzt       Date:  2008-04       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.